메뉴 건너뛰기




Volumn 49, Issue 10, 2014, Pages 942-949

Original article: Inpatient prescribing and monitoring of fentanyl transdermal systems: Adherence to safety regulations

Author keywords

adverse drug event; fentanyl transdermal; health care informatics; medication safety

Indexed keywords

FENTANYL;

EID: 84913612061     PISSN: 00185787     EISSN: 19451253     Source Type: Journal    
DOI: 10.1310/hpj4910-942     Document Type: Article
Times cited : (12)

References (17)
  • 1
    • 84913615318 scopus 로고    scopus 로고
    • Titusville NJ: Janssen Pharmaceuticals Inc
    • Duragesic [package insert]. Titusville, NJ: Janssen Pharmaceuticals, Inc; 2012
    • (2012) Duragesic Package Insert
  • 2
    • 0005248386 scopus 로고    scopus 로고
    • Information for healthcare professionals: Fentanyl transdermal system (marketed as Duragesic and generics Published December 21 2007. Updated September 30, 2009. Accessed August 28
    • Information for healthcare professionals: Fentanyl transdermal system (marketed as Duragesic and generics). US Food and Drug Administration Web site. http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm084307.htm. Published December 21, 2007. Updated September 30, 2009. Accessed August 28, 2012
    • (2012) US Food and Drug Administration Web Site
  • 3
    • 84876730585 scopus 로고    scopus 로고
    • REMS). US Food and Drug Administration Web site. Updated July 2012. Accessed August 28
    • Extended-release (ER) and long-acting (LA) opioid analgesics risk evaluation and mitigation strategy (REMS). US Food and Drug Administration Web site. http://www.fda.gov/downloads/drugs/drugsafety/postmarketdrugsafetyinformationforpatientsandproviders/ucm311290.pdf. Updated July 2012. Accessed August 28, 2012
    • (2012) Extended-release (ER) and Long-acting (LA) Opioid Analgesics Risk Evaluation and Mitigation Strategy
  • 5
    • 0003413171 scopus 로고    scopus 로고
    • Washington DC: National Academy Press Accessed January 5 2014
    • Kohn LT, Corrigan J, Donaldson MS. To Err Is Human: Building a Safer Health System. Washington, DC: National Academy Press; 2000. http://www.iom.edu/~/media/Files/Report%20Files/1999/To-Err-is-Human/To%20Err%20is%20Human%201999%20%20report%20brief.pdf. Accessed January 5, 2014
    • (2000) To Err Is Human: Building A Safer Health System
    • Kohn, L.T.1    Corrigan, J.2    Donaldson, M.S.3
  • 6
    • 0029066463 scopus 로고
    • Incidence of adverse drug events and potential adverse drug events implications for prevention
    • Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. JAMA. 1995;274(1):29-34
    • (1995) JAMA , vol.274 , Issue.1 , pp. 29-34
    • Bates, D.W.1    Cullen, D.J.2    Laird, N.3
  • 7
    • 57149113185 scopus 로고    scopus 로고
    • ASHP national survey on informatics: Assessment of the adoption and use of pharmacy informatics in US hospitals
    • Pederson CA, Gumpper KF. ASHP national survey on informatics: Assessment of the adoption and use of pharmacy informatics in US hospitals. Am J Health Syst Pharm. 2008;65:2244-2464
    • (2008) Am J Health Syst Pharm , vol.65 , pp. 2244-2464
    • Pederson, C.A.1    Gumpper, K.F.2
  • 9
    • 76149096526 scopus 로고    scopus 로고
    • Launching hitech
    • Blumenthal D. Launching HITECH. N Engl J Med. 2010;362:382-385
    • (2010) N Engl J Med , vol.362 , pp. 382-385
    • Blumenthal, D.1
  • 10
    • 35648934133 scopus 로고    scopus 로고
    • ISMP medication error report analysis: Ongoing incidents involving fentanyl patches are alarming; Insulin concentrate u-500; Who: Dilute vincristine in a minibag
    • Cohen MR, Smetzer JL. ISMP Medication Error Report Analysis: Ongoing incidents involving fentanyl patches are alarming; Insulin concentrate U-500; WHO: dilute vincristine in a minibag. Hosp Pharm. 2007;42(10):884-888
    • (2007) Hosp Pharm , vol.42 , Issue.10 , pp. 884-888
    • Cohen, M.R.1    Smetzer, J.L.2
  • 11
    • 33646444297 scopus 로고    scopus 로고
    • Is the use of transdermal fentanyl inappropriate according to the who guidelines and the eapc recommendations? A study of cancer patients in Italy
    • Ripamonti C, Fagnoni E, Campa T, et al. Is the use of transdermal fentanyl inappropriate according to the WHO guidelines and the EAPC recommendations?. A study of cancer patients in Italy. Support Care Cancer. 2006;14(5):400-407
    • (2006) Support Care Cancer , vol.14 , Issue.5 , pp. 400-407
    • Ripamonti, C.1    Fagnoni, E.2    Campa, T.3
  • 12
    • 70349745416 scopus 로고    scopus 로고
    • Frequency of longacting opioid analgesic initiation in opioid-naïve nursing home residents
    • Dosa AM, Dore DD, Mor V, Teno JM. Frequency of longacting opioid analgesic initiation in opioid-naïve nursing home residents. J Pain Symptom Manage. 2009;38(4):515-521
    • (2009) J Pain Symptom Manage , vol.38 , Issue.4 , pp. 515-521
    • Dosa, A.M.1    Dore, D.D.2    Mor, V.3    Teno, J.M.4
  • 13
    • 84856266945 scopus 로고    scopus 로고
    • Utilisation of transdermal fentanyl in germany from 2004 to 2006
    • Garbe E, Jobski K, Schmid U. Utilisation of transdermal fentanyl in Germany from 2004 to 2006. Pharmacoepidemiol Drug Saf. 2012;21(2):191-198
    • (2012) Pharmacoepidemiol Drug Saf , vol.21 , Issue.2 , pp. 191-198
    • Garbe, E.1    Jobski, K.2    Schmid, U.3
  • 14
    • 84873473756 scopus 로고    scopus 로고
    • Pharmacy-based medication reconciliation program utilizing pharmacists and technicians: A process improvement initiative
    • Smith SB, Mango Md. Pharmacy-based medication reconciliation program utilizing pharmacists and technicians: A process improvement initiative. Hosp Pharm. 2013; 48(2):112-119
    • (2013) Hosp Pharm , vol.48 , Issue.2 , pp. 112-119
    • Smith, S.B.1    Mango Md.2
  • 15
    • 73649116397 scopus 로고    scopus 로고
    • Medication reconciliation at an academic medical center: Implementation of a comprehensive program from admission to discharge
    • Murphy EM, Oxencis CJ, Klauck JA, et al. Medication reconciliation at an academic medical center: Implementation of a comprehensive program from admission to discharge. Am J Health Syst Pharm. 200966(23):2126-2131
    • (2009) Am J Health Syst Pharm , vol.66 , Issue.23 , pp. 2126-2131
    • Murphy, E.M.1    Oxencis, C.J.2    Klauck, J.A.3
  • 16
    • 33744482871 scopus 로고    scopus 로고
    • January 1, 2014. Accessed February 23
    • National Patient Safety Goals effective January 1, 2014. http://www.jointcommission.org/assets/1/6/HAP-NPSG- Chapter-2014.pdf. Accessed February 23, 2014
    • (2014) National Patient Safety Goals Effective
  • 17
    • 80955140381 scopus 로고    scopus 로고
    • Pharmacist documentation of fentanyl patch orders in an academic medical center
    • Jahansouz F, Hsiao J, Dhillon K, et al. Pharmacist documentation of fentanyl patch orders in an academic medical center. Hosp Pharm. 2011;46(11):854-863
    • (2011) Hosp Pharm , vol.46 , Issue.11 , pp. 854-863
    • Jahansouz, F.1    Hsiao, J.2    Dhillon, K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.